Related Experiment Videos

The decrease of mitochondrial NADH dehydrogenease and drug induced apoptosis in doxorubicin resistant A431 cells

T W Wong1, H Y Yu, S K Kong

  • 1Department of Biochemistry, The Chinese University of Hong Kong, Shatin.

Life Sciences
|August 23, 2000
PubMed

Insights

Doxorubicin resistance in A10A cells is linked to reduced apoptosis and lower reactive oxygen species (ROS) generation. Down-regulation of mitochondrial NADH dehydrogenase III (ND3) may explain this resistance mechanism.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Doxorubicin (DOX) is a chemotherapy drug that induces apoptosis.
  • Acquired resistance to DOX is a significant clinical challenge.
  • Understanding resistance mechanisms is crucial for improving cancer therapy.

Purpose of the Study:

  • To investigate the mechanisms of Doxorubicin resistance in A10A cells, a human squamous carcinoma cell line.
  • To identify molecular factors contributing to reduced apoptosis and altered cellular responses to DOX.

Main Methods:

  • Comparative analysis of apoptosis induction by DOX in parent A431 cells and DOX-resistant A10A cells.
  • Assessment of reactive oxygen species (ROS) generation and mitochondrial depolarization.
  • RT-PCR based differential display to identify differentially expressed genes.
  • Sequence homology analysis of identified clones.

Main Results:

  • A10A cells showed significantly less apoptosis following DOX treatment compared to parent cells.
  • DOX-induced ROS formation and mitochondrial depolarization were less pronounced in A10A cells.
  • Catalase partially reversed DOX effects, confirming ROS involvement in apoptosis.
  • Differential display identified a down-regulated clone with homology to mitochondrial NADH dehydrogenase III (ND3) gene in A10A cells.

Conclusions:

  • Reduced apoptosis and ROS generation contribute to DOX resistance in A10A cells.
  • Down-regulation of the mitochondrial ND3 gene may be a key factor in DOX resistance.
  • Targeting ND3 or related pathways could offer strategies to overcome DOX resistance.

Related Concept Videos